News | Artificial Intelligence | August 05, 2019

Hospital is the first in the NY Metro area to use AI for emergency imaging

Montefiore Nyack Hospital Uses Aidoc AI to Spot Urgent Conditions Faster

August 5, 2019 — Montefiore Nyack Hospital, an acute care hospital in Rockland County, N.Y., announced it is utilizing artificial intelligence (AI) software to assist in identifying urgent life-threatening conditions on patient computed tomography (CT) scans. The commercial solution from medical AI company Aidoc automatically prioritizes critical medical conditions, ensuring patients are diagnosed and treated faster. Montefiore Nyack is the first regional hospital in the New York metropolitan area to use Aidoc, joining more than 160 medical centers worldwide.

A member of the academic medical center Montefiore Health System, Montefiore Nyack Hospital has developed a reputation for working with industry to help develop and implement state-of-the-art technology to improve patient care. 

“Incorporating artificial intelligence into our workflow process enables our physicians to expedite care for our most critical patients,” said Evan Kaminer, M.D., director of radiology and president of the medical staff at Montefiore Nyack Hospital. “The integration of Aidoc was fast and seamless, and the results were witnessed almost immediately. In one month alone, Aidoc flagged 77 patients with acute intracranial hemorrhage.”

“We are happy to be able to partner with a technology leader such as Aidoc,” said Mark Geller, M.D., president and CEO of Montefiore Nyack Hospital. “We are thrilled to be able to include this revolutionary technology in the care of our community.”

Aidoc has integrated Change Healthcare Workflow Intelligence radiology workflow manager, already in use by Montefiore Nyack. With this new integration, Aidoc has built a strong AI collaboration with Change Healthcare, providing radiologists with a unified AI-driven workflow. 

Aidoc’s always-on solution has three U.S. Food and Drug Administration (FDA) clearances for flagging intracranial hemorrhage, cervical spine fracture and pulmonary embolism — life-threatening conditions that need immediate treatment. Aidoc works alongside radiologists by prioritizing these critical cases, moving them to the top of the worklist to be diagnosed immediately. In the most urgent cases, Aidoc can cut the time from scan to diagnosis to just a few minutes. 

For more information: www.aidoc.com


Related Content

News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | Computed Tomography (CT)

April 2, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for True ...

Time April 03, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
News | Computed Tomography (CT)

March 30, 2026 — HCA Healthcare’s Good Samaritan Hospital is the first hospital in the Bay Area to implement Lumina 3D ...

Time April 01, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets ...

Time March 26, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
Subscribe Now